Raising in Biological Technology

Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets

LONDON, February 24 /PRNewswire/ -- - Syndicate Comprises Leading Sector Investors Clarus Ventures, MVM Life Science Partners and Novartis Option Fund Heptares Therapeutics Ltd, the drug discovery company focused on drugs targeting G-protein-coupled receptors (GPCRs), announces t...

Arbel Medical has Completed a $4.5 million Round of Capital Raising led by Giza Venture Capital Fund

YOKNEAM, Israel, July 17 /PRNewswire/ -- Arbel Medical, an Israeli start-up developing the next generation of medical equipment for removing tumors by freezing (cryotherapy), has completed raising $4.5 million of capital in its second round, led by the Giza Venture Capital fund. The Docor In...

MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million

GERMANTOWN, Md., Jan. 30 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK ), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that it has closed its previously announced private placement of common stock...

Novagali Pharma Completes a EUR15 Million Fund Raising

EVRY, France, September 26 /PRNewswire/ -- Novagali Pharma, a French Laboratory specialized in ophthalmology announces today it has secured EUR15 million in a new financing round with the participation of the historical Company investors. Thanks to this new contribution Novagali Pharma will ...

The mechanics of raising capital for your business

From the earliest "idea-stage" start-ups to some of the largest of the Fortune 500, most companies, even publicly traded ones, raise equity capital through private placements. A private placement, sometimes referred to as a private offering, is a sale of "restricted securities" by an issuing c...

Securities compliance is part of raising capital

For most people, a natural biological response to the phrase securities law requirements is the formation of a thin, opaque film over the outside of the cornea wall, coupled with a dull look and slumping shoulders. To avoid this, I will do my best to stick to the essentials. As a result, however,...

Data centers: Blowing smoke and raising red flags

Last week in Orlando, I spoke at the well-attended BICSI Conference . While I was there, I also wanted to visit one of PEAK 10's data centers to get a first-hand view of its services. Last year, I wrote about PEAK 10 after doing some online research, and I figured I would have a chance to g...

Early Stage, Step 9: Raising capital in the securities landscape

Editor's note: This is the ninth in a series of articles on developing start-up companies in the technology or biotechnology sectors. The most recent article focused on worker classification. Madison, Wis. - The idea is developed. Lawyers and accountants are on board. The intellectual prop...

When raising capital, why use a Private Placement Memorandum?

Editor's note: Matt Storms is writing a series of articles on raising capital from angel and venture capital investors. This installment focuses on the Private Placement Memorandums, or PPMs, and is co-written with Dan Ghoca. We are frequently asked whether it is necessary to use a private p...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

...bligations and unless unforeseen events arise that negatively impact our liquidity. In the event we are unsuccessful generating additional revenues or raising additional funds, we will have to substantially reduce our operations to preserve capital or seek bankruptcy protection or otherwise wind up our busin...

Novavax Reports Second Quarter 2009 Financial Results

... when compared to December 31, 2008. Since the first quarter, Novavax continued to advance its vaccine pipeline, improved its balance sheet by raising additional capital and retiring 100% of its convertible debt, and entered into an initial agreement with ROVI Pharmaceuticals of Spain ("ROVI"). ...

GenVec Reports Second Quarter 2009 Financial Results

...ify new immunogenic antigens for malaria vaccine development. Other Developments GenVec strengthened its cash position by raising $6.0 million from a single institutional investor. Proceeds of this transaction, net of offering costs, totaled $5.5 million. Conferen...

China Sky One Medical, Inc. Appoints New Independent Director

..., Mr. Wei Lee has been a Managing Director with Transworld Capital Group, a U.S. investment service firm specializing in cross-border M&A and fund raising between U.S. and China. In 2008, he served as Chief Operating Officer (on loan) for Legend Media Corporation, a U.S.-listed company specializing in ra...

Microbia Names John McCarthy to Senior Management Team

...nce to Microbia from the broad healthcare and alternative energy industries, including having led three IPOs, numerous corporate partnerships, and the raising of over $1 billion of capital in the private and public markets. Most recently, he served as Executive Vice President and Chief Financial Officer of V...

Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.

... its clinical trials and other operating activities, and repay indebtedness in due course. Shareholders should be aware that if the Company's capital raising efforts are unsuccessful, this will have a material adverse effect on the Company's financial position and operations. About Northwest Bi...

BioNeutral's Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms

...om ATS show that we have developed what we believe is the best, and I emphasize the best, antimicrobial coming to the market. By using the strategy of raising the bar for antimicrobial performance, we believe our superior Ygiene(TM) Hospital Grade antimicrobial will provide much cleaner, safer and healthier ...

Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference

...Lamont, Inc. has an extensive history on Wall Street, with its origins encompassing such successes as providing brokerage services to Standard Oil and raising capital for the construction of Rockefeller Center. Jesup & Lamont, through its two wholly owned brokerage subsidiaries, offers full service broke...

ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009

...f the remaining development activities leading to an NDA submission, we determined that the value of ANX-530 to our stockholders would be maximized by raising the necessary capital to move forward independently. This decision and our ability to file the NDA rely upon the continued availability of capital fo...

Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations Symposium

...ed is never give up because the world keeps changing. Keep going forward on all fronts and never give up because everything is dynamic right now. Keep raising awareness about your company and building networks and getting well known." John Pennett , C.P.A., a Partner and Director of Life Sciences wit...

Shawn Cross Joins Burrill Merchant Banking

...structuring and completing mergers and acquisitions, partnering and capital raising transactions. In addition, Shawn will make an important contribution to the... activities." "The strategy to combine M&A, partnering and capital raising advisory services with the deployment of our own private equity and venture...

Campbell Alliance Launches New Practice Area Focused on Medical Affairs

...seven-year tenure at Campbell Alliance, he has led a wide range of medical affairs-related projects. "Regulatory and drug safety requirements are raising the profile of the medical affairs function and the needs filled by professionals working in this field," said Mr. Dietlin. "Campbell Alliance unders...

Top CEOs Declare America's Manufacturing Sector Requires Pro-Industry Policies, Capital Management and Innovation to Maintain Economic Leadership

.... According to Engler, the federal government needs to consider the long-term impact that increasing costs, adding new regulations, raising taxes and expanding litigation will have on America's future economic competitiveness. "Prosperity comes from building, creating and producing," ...

Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update

... the third quarter of fiscal 2009. Also, increased expenditures are associated with the implementation of a new financial reporting system and capital raising initiatives. Offsetting some of the aforementioned increases in expenditures are lower wages and benefits from the foregoing of accrued vacation days...

BIOCOM's Inaugural CALAsia Forum 'Bridging the Pacific'

...ic Region Across The Value Chain Let's Discuss Innovation in the Asia-Pacific Region Bay Helix Bio Pharmaceutical Perspectives raising Money in Asia Evolving Intellectual Property Rights in China and India For specific dates and times, please visit: www....

Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis

.... Factors which may significantly change or prevent the Company's forward looking statements from fruition include: that Raptor may be unsuccessful at raising funds to continue its development programs; Raptor may be unsuccessful in developing any products or acquiring products; that Raptor's technology may ...

Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States

...- baseball. "The only weapon we currently have against this disease is raising awareness and funds for research. The BBQ For ALS Awareness program is a ...July 4, 2009 as part of MLB's 4ALS Awareness campaign. "In addition to raising research funds, this program aims to ensure that new generations of America...

PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration

...orts. Since its inception, the Foundation has awarded over $60 million in sponsored research agreements. In addition, the Foundation is committed to raising awareness and generating support for increased research efforts in SMA among the leaders of industry and government. For more information on the Spin...

Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance

...s it has already received and continues to receive from the independent distributors. Revised Revenue and Net Income Guidance Yongye is raising its previously announced revenue and net income guidance because of increased sales supported by this current financing. Yongye revises its previously...

Novavax Reports First Quarter 2009 Financial Results

...ts vaccine pipeline, improved its balance sheet by raising capital and retiring a majority of its convertible...Novavax's option. Increased liquidity by raising $11.0 million from sale of 12.5 million shares of ...lly owned subsidiary of Cadila Pharmaceuticals and raising approximately $7.5 million from the sale of approx...

Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results

...009," stated Ted Schroeder, President and CEO of Cadence Pharmaceuticals. "We also achieved another important corporate objective earlier this year by raising gross proceeds of $86.6 million through a private placement of common stock and warrants. We believe this additional capital strengthens our balance s...

The Crohn's & Colitis Foundation of America and Shire Launch Virtual 'IBD March on the Hill' to Increase Funding for Digestive Disease Research

...hire will donate $1 per footstep to CCFA for research, education and support initiatives for each of the first 30,000 steps taken. In addition to raising funds for IBD research, the virtual march gives those affected by IBD the opportunity to support the more than 75 patient advocates who are in Washing...

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

...erase inhibitor and protease inhibitor in the absence of interferon in patients infected with HCV. We also recently strengthened our balance sheet by raising $63 million in cash and by exchanging $32 million in convertible debt for shares of our common stock. The remainder of 2009 is expected to be as prod...

Nanophysicists find unexpected magnetic effect

...boratory in Alicante, Spain, in 2008. Calvo, a graduate student, was working with single-atom ferromagnetic contacts that were created by lowering and raising the tip of a scanning tunneling microscope onto a surface. Untiedt knew that Natelson worked on similar-sized systems that were created in a wholly...

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

...als. "I can say without reservation that our companies have excelled due to his successes." As Vice President, Mr. Lea will manage DFB's capital raising and financing activities, business development initiatives and strategic planning. He will also be responsible for business development efforts for H...

WaferGen Announces Signing of Private Financing

...ditions and there can be no assurance that the closing of the financing will occur in a timely manner, if at all. "We are pleased to announce the raising of additional capital to support our ongoing development and commercialization of the SmartChip Real-Time PCR System. We believe that the fact that w...

Physicists discover important step for making light crystals

...ed spin. When fermions are hot, they spin chaotically. The hotter the atoms, the more disordered these spins become. Ho and Zhou discovered that by raising the laser intensity, researchers could compress the fermions into a so-called "band insulator," where each cell in the lattice contains two fermions i...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables

...o $32.9 million, compared to the beginning of 2008, due to an increase in operation profits, improved accounts receivable collection and raising capital. Business Highlights -- In 2008, Sinovac initiated the development program of a vaccine against enterovirus 71 (EV 71), which ...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results

...o $32.9 million, compared to the beginning of 2008, due to an increase in operation profits, improved accounts receivable collection and raising capital. Business Highlights -- In 2008, Sinovac initiated the development program of a vaccine against enterovirus 71 (EV 71), which ...

Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry

...zerland, further development plans for Oxycyte(R) in indications beyond traumatic brain injury, supply plans for clinical-grade Oxycyte, and plans for raising additional capital. The blog is available on the company's Electronic Shareholder Forum which can be found via the Investor Relations page of th...

New Clinical Study Shows Masimo PVI(TM) Accurately Predicts Fluid Responsiveness in the ICU

...eness. In the first step, researchers infused fluid (500 ml saline) in with pulse pressure variation (PPV) >/= 15% and performed passive leg raising in patients with PPV <15% while simultaneously recording Masimo PVI and PPV. A >15% increase in velocity-time-integral (VTI) from echocardiogra...